View All News

Allentown Pharma Firm Hopes To Soon Have Oral Vaccine To Market

July 20, 2022

With Phase 1 testing now complete and showing positive results, U.S.

Specialty Formulations of Allentown is moving forward with the oral COVID-19 vaccine that it is producing.

Read More

Comments are closed.

Written by

GamePlanX Network of Experts

Specializing in pharmaceutical manufacturing, regulatory‑compliant digital marketing, and healthcare industry growth strategies. This multidisciplinary team provides subject‑matter expertise relevant to USSF’s cGMP operations, botanical injectables, and clinical education initiatives.